ETON — Eton Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.43bn
- $1.43bn
- $79.95m
Brief: Eton Terminated Asset Purchase Deal With Wellstat Therapeutics Corp & Wellstat Biologics Corp
U.S. STOCKS ON THE MOVE-Louisiana-Pacific, Jefferies Financial Group, Beazer Homes
U.S. STOCKS ON THE MOVE-Netflix, Genprex, Joby Aviation
U.S. STOCKS ON THE MOVE-Cognition Therapeutics, Pinterest, Minerva Neurosciences
U.S. STOCKS ON THE MOVE-Overstock.com, Reata Pharma, Boeing
Eton Pharma falls as US FDA declines to approve methanol poisoning treatment
Brief: Eton Pharmaceuticals Receives Complete Response Letter (CRL) For Dehydrated Alcohol Injection
Brief: Eton Pharmaceuticals Enters Into Amendment To Asset Purchase
Eton Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
Brief: Eton Pharmaceuticals Announces Commercial Availability Of Betaine Anhydrous For Oral Solution
Eton Pharmaceuticals Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Eton Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million - SEC Filing
Brief: Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
Eton Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eton Pharmaceuticals Inc expected to post earnings of 1 cent a share - Earnings Preview
Eton Pharmaceuticals Inc expected to post earnings of 1 cent a share - Earnings Preview
Eton Pharma rises as FDA accepts methanol poisoning drug application
Brief: Eton Pharmaceuticals Announces FDA Acceptance Of NDA Response For Dehydrated Alcohol Injection